$6.65
0.81% today
Nasdaq, Feb 28, 05:22 pm CET
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock price

$6.70
-0.20 2.90% 1M
+0.47 7.54% 6M
-0.26 3.74% YTD
+1.14 20.50% 1Y
-11.60 63.39% 3Y
+0.70 11.67% 5Y
-20.24 75.13% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.12 1.76%
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Key metrics

Market capitalization $188.69m
Enterprise Value $-82.28m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 1.12
P/B ratio (TTM) P/B ratio 2.08
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-93.66m
Free Cash Flow (TTM) Free Cash Flow $-73.36m
Cash position $295.28m
EPS (TTM) EPS $-2.09
P/E forward negative
Short interest 14.01%
Show more

Is Mind Medicine Inc - Ordinary Shares (Sub Voting) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

Buy
100%

Financial data from Mind Medicine Inc - Ordinary Shares (Sub Voting)

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 1.32 1.32
59% 59%
-
-1.32 -1.32
59% 59%
-
- Selling and Administrative Expenses 37 37
13% 13%
-
- Research and Development Expense 54 54
16% 16%
-
-92 -92
12% 12%
-
- Depreciation and Amortization 1.32 1.32
59% 59%
-
EBIT (Operating Income) EBIT -94 -94
9% 9%
-
Net Profit -98 -98
27% 27%
-

In millions USD.

Don't miss a Thing! We will send you all news about Mind Medicine Inc - Ordinary Shares (Sub Voting) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock News

Neutral
Business Wire
8 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, a...
Positive
The Motley Fool
14 days ago
Mind Medicine (MNMD 15.66%) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m.
Neutral
Business Wire
24 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference: Oppenheimer 35th Annual Healthcare Life Scien...
More Mind Medicine Inc - Ordinary Shares (Sub Voting) News

Company Profile

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.

Head office Canada
CEO Robert Barrow
Employees 57
Founded 2019
Website www.mindmed.co

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today